Protea Biosciences Group (PRGBQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83 | 16 | 79 | 0 | 174 |
| Receivables | 203 | 89 | 437 | 340 | 375 |
| Inventories | 38 | 41 | 92 | 146 | 147 |
| TOTAL | $500 | $296 | $729 | $556 | $818 |
| Non-Current Assets | |||||
| PPE Net | 2,306 | 2,339 | 2,466 | 2,758 | 2,847 |
| Other Non-Current Assets | 19 | 19 | 19 | 19 | 5 |
| TOTAL | $2,325 | $2,358 | $2,485 | $2,777 | $2,852 |
| Total Assets | $2,825 | $2,654 | $3,214 | $3,333 | $3,670 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,158 | 7,990 | 10,100 | 10,030 | 6,114 |
| Accounts payable and accrued liabilities | 1,143 | 1,712 | 1,796 | 1,891 | 1,299 |
| Other current liabilities | 2,554 | 7,542 | 3,654 | 5,481 | 2,197 |
| TOTAL | $12,855 | $17,244 | $15,551 | $17,402 | $9,610 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,776 | 1,834 | 1,769 | 1,838 | 4,919 |
| TOTAL | $1,776 | $1,834 | $1,769 | $1,838 | $4,919 |
| Total Liabilities | $14,631 | $19,078 | $17,320 | $19,239 | $14,529 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,941 | 4,303 | 4,198 | 2,986 | 2,674 |
| Common Shares | 40 | 21 | 16 | 13 | 13 |
| Retained earnings | -106,612 | -101,110 | -95,246 | -88,009 | -82,491 |
| TOTAL | $-11,806 | $-16,424 | $-14,106 | $-15,907 | $-10,859 |
| Total Liabilities And Equity | $2,825 | $2,654 | $3,214 | $3,333 | $3,670 |